General MedicationsINJECTIONStandard
DRAXIMAGE MDP-25
TECHNETIUM TC-99M MEDRONATE
Standard Dose
N/A
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary
Approval overview DRAXIMAGE MDP-25 is listed in Drugs@FDA under application 018035 (NDA).
Review priority: STANDARD Marketing status: Prescription Active ingredient TECHNETIUM TC-99M MEDRONATE Form and strength INJECTABLE;INJECTION - N/A Sponsor JUBILANT Submission history Latest submission status date: 2025-05-22 00:00:00.
Structured Monograph
Clinical summary
Approval overview DRAXIMAGE MDP-25 is listed in Drugs@FDA under application 018035 (NDA). Review priority: STANDARD Marketing status: Prescription Active ingredient TECHNETIUM TC-99M MEDRONATE Form and strength INJECTABLE;INJECTION - N/A Sponsor JUBILANT Submission history Latest submission status date: 2025-05-22 00:00:00. Submission type: SUPPL.
Monitoring
- • Marketing status: Prescription
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.